New Perspectives in Rheumatology: Avoiding Antimalarial Toxicity.
This report inaugurates New Perspectives in Rheumatology, a series of authoritative articles that focus on recent scientific and clinical developments and their potential to reshape rheumatology practice. Anticipated topics include the implementation of new guidelines and emerging information from clinical and translational research. Richard J. Bucala, MD, PhDEditor-in-ChiefRobert Terkeltaub, MDCo-Editor and Review Article Editor.
Oregon Health & Sciences University and Legacy Devers Eye Institute, Portland.
James T
JT
Rosenbaum
Oregon Health & Sciences University, Portland.
George R
GR
Mount
Oregon Health & Sciences University, Portland.
Jameel
J
Youssef
Oregon Health & Sciences University, Portland.
Phoebe
P
Lin
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use; D001692:Biological Transport; D016903:Drug Monitoring; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D012164:Retinal Diseases / Q000139:chemically induced*; D012216:Rheumatic Diseases
D000962:Antimalarials; D006886:Hydroxychloroquine